Handelsbanken Fonder AB Buys 41,605 Shares of Intuitive Surgical, Inc. $ISRG

Handelsbanken Fonder AB lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 357,586 shares of the medical equipment provider’s stock after purchasing an additional 41,605 shares during the quarter. Intuitive Surgical accounts for about 0.6% of Handelsbanken Fonder AB’s holdings, making the stock its 22nd largest position. Handelsbanken Fonder AB’s holdings in Intuitive Surgical were worth $202,522,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in ISRG. Brighton Jones LLC increased its stake in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares during the last quarter. Sivia Capital Partners LLC increased its stake in Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after acquiring an additional 34 shares during the last quarter. Schnieders Capital Management LLC. increased its stake in Intuitive Surgical by 38.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after acquiring an additional 268 shares during the last quarter. Osterweis Capital Management Inc. bought a new position in Intuitive Surgical in the 2nd quarter worth about $200,000. Finally, Main Street Financial Solutions LLC increased its stake in Intuitive Surgical by 92.4% in the 2nd quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock worth $1,592,000 after acquiring an additional 1,407 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Evercore decreased their target price on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a research note on Monday, April 6th. The Goldman Sachs Group upped their target price on Intuitive Surgical from $609.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday, April 22nd. Argus decreased their target price on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Robert W. Baird upped their target price on Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. Finally, Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday. Nineteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $579.33.

Insider Activity at Intuitive Surgical

In related news, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $446.95, for a total transaction of $178,780.00. Following the completion of the sale, the executive vice president directly owned 6,120 shares in the company, valued at $2,735,334. This represents a 6.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Mark Brosius sold 645 shares of the stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $485.01, for a total value of $312,831.45. Following the sale, the senior vice president owned 1,613 shares of the company’s stock, valued at $782,321.13. This represents a 28.57% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 5,647 shares of company stock worth $2,760,359 over the last three months. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Trading Up 4.5%

ISRG opened at $439.92 on Tuesday. The stock has a 50-day moving average price of $462.50 and a 200-day moving average price of $513.03. Intuitive Surgical, Inc. has a 12-month low of $417.74 and a 12-month high of $603.88. The stock has a market capitalization of $155.80 billion, a P/E ratio of 53.32, a PEG ratio of 3.36 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same period in the prior year, the business earned $1.81 EPS. The company’s revenue for the quarter was up 23.0% compared to the same quarter last year. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.